Not Signed In -
Hydroxychloroquine |
Plaquenil |
Hydroxychloroquine Systematic (IUPAC) name 2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol Identifiers CAS number 118-42-3 ATC code P01BA02 PubChem 3652 Chemical data Formula C18H26N3ClO Mol. weight 335.872 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life 1-2 months Excretion Renal Therapeutic considerations Pregnancy cat. D (Au), C (U.S.) Legal status POM (UK), ℞-only (U.S.) Routes Oral H ...
Wikipedia - [full article]
Hydroxychloroquine Clinical Trials
- Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus
ClinicalTrials.gov Identifier: NCT00102557 - Completed
- Hydroxychloroquine, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00486603 - Recruiting
Brain and Central Nervous System Tumors
- Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00568880 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
ClinicalTrials.gov Identifier: NCT00031824 - Completed
Graft Versus Host Disease
- Hydroxychloroquine in Cystic Fibrosis
ClinicalTrials.gov Identifier: NCT00311883 - Recruiting
Cystic Fibrosis
- Hydroxychloroquine in Giant Cell Arteritis
ClinicalTrials.gov Identifier: NCT00430807 - Terminated
Giant Cell Arteritis
Resources
- Hydroxychloroquine (Drug Digest)
- Plaquenil (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
